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(popliteal 122 (29%), tibial 238 (56%), pedal 63 (15%)) were
analyzed.
258 (61%) patients received a single segment GSV, 118 (28%) an
AAV and 47 (11%) a prosthetic conduit. Postoperative outcomes
had no signiﬁcant differences among groups. Primary patency at 2
years for the GSV, AAV and prosthetic groups was 47%, 26% and
40% respectively. AAV demonstrated the poorest primary patency
rates, though non-statistically signiﬁcant compared to the pros-
thetic group (P ¼ .068). Primary assisted patency at 2 years for the
GSV, AAV and prosthetic groups was 70%, 52% and 45% respec-
tively. The primary-assisted patency of GSV was signiﬁcantly su-
perior to both AAV (P ¼ .008) and prosthetic grafts (P ¼ .002),
which did not differ signiﬁcantly from one another (P ¼ .479).
Secondary patency at 2 years for the GSV, AAV and prosthetic
groups was 75%, 57% and 46% respectively and again AAV and
prosthetic grafts did not differ signiﬁcantly from one another (P ¼
.212). In Cox regression analysis primary, primary assisted and
secondary patency were positively predicted by GSV (HR 1.65, P ¼
.001; HR 1.65, P ¼ .006; HR 1.72, P ¼ .006 respectively) when
compared to AAV, but there was no difference between AAV and
prosthetic grafts. Neither target artery (popliteal vs. tibial/pedal)
or runoff score, nor statins showed any predictive value. Limb
salvage at 2 years for the GSV, AAV and prosthetic groups was
87%, 77% and 74% respectively with no signiﬁcant differences
among groups.
Conclusion: When GSV is not available, alternative autologous vein
conduits do not offer a signiﬁcant patency advantage in midterm
follow up over prosthetic bypasses for below knee targets.The Receptor for Advanced Glycation End Products (RAGE) and
its Ligands in Plasma and Infrainguinal Bypass Vein
J. Malmstedt
Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Introduction: Objective: To investigate if RAGE and its ligands are
associated with outcome in patients with and without diabetes
undergoing infrainguinal bypass surgery.
Methods: A prospective observational study with at least 3 years
follow upwas conducted in 68 patients (57%male) with (n¼ 38) and
without (n ¼ 30) diabetes undergoing their ﬁrst elective infrain-
guinal vein bypass due to peripheral arterial occlusive disease.
Endosecretory RAGE (esRAGE), S100A12, advanced glycation end
products and carboxymethyl-lysine (CML) were determined in
plasma using ELISA. Inﬂuence of plasma levels on themain outcome
measure (amputation free survival) was evaluated using Cox pro-
portional hazard regression analysis. Plasma levels of esRAGE, CML
and S100A12 in healthy controls (n ¼ 30) without cardiovascular
disease matched for sex and age were compared to patients, using
ManneWhitney U test. S100A12, RAGE, AGE and CML in vein tissue
obtained at bypass surgery were determined using
immunohistochemistry.
Results: Forty-six patients survived with intact leg during a median
follow up of 702 days, (IQR 188 to 899). Seventeen died, and 6
were amputated. High plasma levels of S100A12 were associated
with reduced amputation free survival, (hazard ratio [HR] 2.99;
95% CI 1.24e7.24) when comparing levels above the 75th
percentile with levels below. The increased risk was essentially
unchanged adjusting for age, sex and diabetes (HR 2.58; 95% CI
1.05e6.35).Diabetic patients had higher mean S100A12 plasma levels,
11.75 ng/mL; 95% CI 8.12e15.38 compared to non diabetic pa-
tients 5.01; 3.62e6.41 (P ¼ .002), whereas levels of CML, esRAGE
and AGE were comparable. Mean plasma levels of CML and
S100A12 were higher in patients compared to controls, 1.25 mg/
mL; 95% CI 1.18e1.32 versus 0.89; 0.82e0.96 (P ¼ .001), and 8.73
ng/mL; 95% CI 6.52e10.95 versus 3.47; 2.95e3.99 (P < .001),
respectively. Diabetic patients did not differ from non diabetic
patients in the proportion of vein tissue area stained for AGE
(21%), RAGE (5%), CML (9%) and S100A12 (3%), and staining was
found in all veins with the same percentage in both diabetic and
non diabetic patients.
Conclusion: Plasma levels of S100A12 and CML are elevated in
peripheral arterial occlusive disease and markers of RAGE and its
ligands are found in vein tissue used for bypass. This may indicate a
role for S100A12, CML and RAGE in peripheral arterial disease
complications by activation of the RAGE system.Renal Outcomes Following Fenestrated and Branched
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Introduction: The purpose of this study was to analyze immediate
and long-term renal outcomes (renal function and renal events)
after fenestrated (FEVAR) and branched endovascular aortic
aneurysm repair (BEVAR).
Methods: All FEVAR and BEVAR performed between October 2004
and October 2012 were included in this study. Postoperative acute
renal failure (ARF) was deﬁned and classiﬁed according to the
RIFLE criteria. Renal volume (calculated with a 3D workstation) and
eGFR (estimated with the MDRD formula) were evaluated before
the procedure, before discharge, 12 months after and yearly
thereafter. Renal stent occlusion, dissection, fracture, stenosis,
kink, renal stent related type III endoleak and renal stent sec-
ondary intervention were all considered “renal composite events”
and analyzed. A time-to-event analysis was performed for renal
events and renal secondary interventions.
Results: During the study period, 225 patients were treated with
FEVAR and BEVAR. Renal target vessels (n ¼ 427) were perfused
by fenestrations (n ¼ 274) or branches (n ¼ 53). Median follow-up
was 2.4 years (2.2e2.6). FEVAR and BEVAR were associated with
similar mean renal artery diameter and renal artery angulations.
Preoperative renal stenosis rate was higher with BEVAR (p <
0.021). Technical success was achieved in 96.4% of patients.
Postoperative ARF was depicted in 64 patients (29%), requiring
transient hemodialysis in 12 patients (5.3%) and permanent he-
modialysis in one case (0.44%). An additional 4 patients (1.9%)
required hemodialysis during follow-up. Signiﬁcant decrease in
right renal volume (17.07 cm3; 95% conﬁdence interval (CI),
12.52e21.67), left renal volume (24.55 cm3; 95% CI, 19.14e29.97)
and eGFR (12.54 ml/min per 1.73 m2; 95% CI, 8.43e16.66) were
observed during follow-up (p < 0.000). The 30-day, 1-year and 5-
year freedom from renal composite event was 98.1% (95% CI,
97.2%e99%), 95% (95% CI, 93.5%e96.5%) and 87.5% (95% CI,
84.7%e90%). Freedom for renal composite events was signiﬁ-
cantly higher in FEVAR (p < 0.048) compared to BEVAR. The 30-
day, 1-year and 5-year freedom from renal occlusion was 99.5%
(95% CI, 99%e100%), 98.5% (95% CI, 97.6%e99.4%) and 93.8%
(95% CI, 91.7%e95.9%) after FEVAR and BEVAR (NS). Median time
346 Abstractsto renal related secondary intervention was 450 days (Q1eQ3,
124e991.5) for both procedures.
Conclusion: FEVAR and BEVAR are durable options for the treatment
of complex aortic aneurysms and are associated with a low renal
morbidity rate. Freedom from renal composite events was signiﬁ-
cantly higher with FEVAR. Renal volume is as accurate way to depict
renal dysfunction during follow-up.Angiosome Guided Surgical Revascularization; the Truth and
Falsehood
K. Yie
Sejong General Hospital, South Korea
Introduction: The usefulness of angiosome guided therapy in critical
limb ischemia has been under debating. We tried to evaluate the ef-
ﬁcacy of angiosome guide revascularization comparing the results
between complete revascularization using great saphenous vein (GSV)
Y graft and single graft bypass.
Methods: From Jul 2008 to Dec 2012. a total of 102 CLI patients
underwent BTK or pedal bypass surgery for critical limb ischemia.
71 pts (83 limbs) underwent single graft bypass (Anterior tibial
artery or posterior tibial artery), otherwise 31 patients (37 limbs)
underwent complete revascularization using GSV Y graft.
Results: There is no statistical difference between both two groups
in terms of preoperative demographics, postoperative complica-
tions and mean 3 years follow up results. However, in the patients
who underwent single graft bypass surgery, primary patency is
longer in positive pedal arc group compared to no pedal arch
group (85% in positive pedal arc group vs. 47.6% in no pedal arc
group). In the patients who underwent Y graft bypass surgery,
primary patency was similar in both groups (87.5% in positive arc
group vs. 80% in no pedal arc group).
Conclusion: Angiosome guided treatment is necessary in the cases
of negative pedal arch. If the patients shows negative compatibility
in terms of wound location with angiosome area, and poor pedal
arch, complete revascularization using GSV Y graft or angiosome
guided single bypass surgery is reasonable. Otherwise, if pedal
arch is competent in peri-operative evaluation, single bypass sur-
gery regardless of angiosome is sufﬁcient.One Bout of Calf Raises Induces Improvement of Mitochondrial
Function in Claudicants
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Introduction: Mitochondria in patients with PAD do not produce
as much ATP as mitochondria in normally perfused muscle.
Therefore patients with PAD do not only have a decreased supply
of nutrients and oxygen, as a result of diseased arteries, but the
concurrent mitochondrial respiratory defects also lead to an even
lower ATP production from the amount of O2 present.
Ischemic preconditioning is known to improve functionality and
to increase the number of mitochondria. We wanted to explore
whether any impact on the mitochondria would be seen already
after one bout of training. The extended goal being whether
speciﬁc “mitochondrial training” with increased ATP production to
follow could improve symptoms for patients with claudication.Methods: Two groups were tested: a control group with healthy
elderly individuals (n ¼ 11) and another group with intermittent
claudication (n ¼ 8).
In patients with claudication we used one bout of continuous
calf raises followed by 5 extra repetitions after initiation of pain.
This approach secured local ischemia and reperfusion ¼ ischemic
preconditioning in the gastrocnemius muscle. The control group
performed 100 calf raises.
Biopsies from the gastrocnemius muscle were taken 15 minutes
prior to the training and another four at ﬁxed time intervals (15 min, 1
h, 3 h and 24 h) after the single bout of exercise.
Respiratory capacities were determined by using mitochondrial
respirometry. The main substrates used were octanoylcarnitine,
glutamate (fatty acid oxidation), malate (complex I), succinate
(complex I and II), and FCCP and rotenone (complex II).
Repeated measures mixed model was used for statistical analysis.
Statistical signiﬁcance was indicated by a value of p <0.05.
Results: Within the group of claudicants Complex I respiratory ca-
pacity reached the highest value at 24 hours (15.4 3.14) compared
to the lowest (8.9 3.28), (p¼ 0.04). Also fatty acid oxidationhad the
highest value at 24 hours (9.2 2.56) compared to the lowest (4.7
2.45), (p ¼ 0.07).
Conclusion: The muscular mitochondrial respiratory capacity im-
proves already after one bout of ischemic preconditioning in clau-
dicants. Calf raise exercise with ﬁve extra repetitions after initiation
of pain might therefore be an alternative to reach speciﬁc “mito-
chondrial training” of the gastrocnemius muscle. This concept is
promising and might be a new conservative approach to intermit-
tent claudication; leading to a decrease of necessary vascular
interventions.Inﬂuence of Microbiology and Wound Scores in the Diabetic Foot
Syndrome Outcome
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Introduction: The diabetic foot syndrome (DFS) is an important
complication of DM resulting very often in amputation, disability
and reduced quality of life. Little is known about the relationship
between the different wound classiﬁcations and the microbiology
of DFS. We aimed to identify accurate predictors to establish the
best empiric therapy and to reduce the rate of amputations.
Methods: Prospective study of 250 consecutive patients diagnosed
of DFS from January 2009 to September 2013 attended at our
institution. Tissue samples for culture were obtained at admission
and 48 hours after. Wound classiﬁcation scores were recorded at
admission and a re-evaluation was performed 48 hours after.
Results: Median age was 66 years (22e91), being male 199 pa-
tients (80%). Hundred and ﬁve patients had received antibiotics
prior to hospital admission and 162 (65%) had femoro-popliteal or
tibial ischemia. Osteomyelitis was present on plain X-ray in 51
patients (36%). Infection was mono-microbial in 131 patients
(52%). Staphylococcus aureus was the most frequent pathogen (76
patients, 30%); being MRSA in 26% (20/76) E. coli and E. faecalis
were 2nd and 3rd most frequent pathogens. Two hundred and
nine patients (85%) needed amputation being major in 25 patients
(10%). Seven patients (3%) died during hospitalization. After one
year of follow-up, 51 patients (21%) were readmitted because of
worsening and 38 needed minor or major amputation.
